Disconnect between signalling potency and in vivo efficacy of pharmacokinetically optimised biased glucagon-like peptide-1 receptor agonists. (2020)

First Author: Lucey M
Attributed to:  Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.molmet.2020.100991

PubMed Identifier: 32278079

Publication URI: http://europepmc.org/abstract/MED/32278079

Type: Journal Article/Review

Volume: 37

Parent Publication: Molecular metabolism

ISSN: 2212-8778